查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按處理、產品、應用和最終用戶
市場調查報告書
商品編碼
1494311

歐洲 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按處理、產品、應用和最終用戶

Europe dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 107 Pages | 訂單完成後即時交付

價格

2022年歐洲dPCR和qPCR市值為25.7383億美元，預計2030年將達到51.8296億美元；預計 2022 年至 2030 年複合年成長率為 9.1%。

遺傳性疾病和傳染病發病率的增加推動了歐洲 dPCR 和 qPCR 市場

根據國家組織關於遺傳性疾病或先天性殘疾的資訊，雖然個體遺傳性疾病很少見，但總體而言，被診斷患有遺傳性疾病的人超過 15,500 人。 2020 年 6 月，根據諾華公司（瑞士）的報告，約有 15,000 人患有鐮狀細胞疾病，每年有 270 名新生兒被診斷​​出患有此疾病。 COVID-19 的爆發對聚合酶鍊式反應市場的成長產生了重大影響。臨床診斷市場不斷成長的需求對PCR產業產生了有利的影響。幾乎所有診斷測試都使用 RT-PCR 來測試有 COVID-19 症狀的人，並且醫療保健專家敦促他們進行診斷測試，而當局尚未認可病毒培養測試。大多數生物技術和製藥企業都將精力集中在研發部門，尋找針對 COVID-19 的新化合物或治療方法。 2022年2月，羅氏將新發表的分子實驗室儀器Cobas 5800系統加入其COVID-19 PCR產品組合中，供接受CE認證的國家使用。這些產品包括cobas SARS-CoV-2和甲型/乙型流感檢測，以及cobas SARS-CoV-2定性檢測。透過在低、中和高容量分子實驗室測試需求中提供統一的性能和效率，這些產品拓寬了羅氏診斷的分子產品組合。此外，借助新型緊湊型 Cobas 5800 系統，空間或資源有限的醫療保健組織可以進行全面存取。在由於缺乏資源或空間而無法容納較大設備的國家或地區，這將帶來更好的測試可訪問性。因此，可使用 dPCR 和 qPCR 技術進行診斷和治療的遺傳性疾病和傳染病的發生率不斷增加，支持了歐洲 dPCR 和 qPCR 市場的成長。

歐洲 dPCR 和 qPCR 市場概況

歐洲 dPCR 和 qPCR 市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。政府和私人對高級研究的資助、人工 DNA 合成創新技術的推出以及基於新技術的應用的各種研究的增加可能是推動歐洲這一市場成長的主要因素。此外，各國政府透過激勵條款和研發及新生物技術新創企業免稅來鼓勵創新的努力預計將有利於歐洲 dPCR 和 qPCR 市場在預測年內的成長。然而，英國脫歐對歐盟的影響可能會導致各種聯盟、夥伴關係、合資企業和合作的喪失，進而對歐洲 dPCR 和 qPCR 市場產生負面影響。

歐洲 dPCR 和 qPCR 市場收入及 2030 年預測（百萬美元）

歐洲 dPCR 和 qPCR 市場區隔

歐洲 dPCR 和 qPCR 市場根據治療、產品、應用、最終用戶和國家進行細分。

根據處理方式，歐洲 dPCR 和 qPCR 市場分為定量 PCR (qPCR) 和數位 PCR (dPCR)。到 2022 年，數位 PCR (dPCR) 領域將佔據更大的佔有率。

依產品分類，歐洲 dPCR 和 qPCR 市場分為試劑和耗材、儀器以及軟體和服務。 2022 年，試劑和耗材領域佔最大佔有率。

依應用分類，歐洲 dPCR 和 qPCR 市場分為研究應用、臨床應用和法醫應用。 2022年，臨床應用領域佔據最大佔有率。

按最終用戶分類，歐洲 dPCR 和 qPCR 市場分為醫院和診斷中心、製藥和生物技術公司、研究實驗室和學術機構、法醫實驗室和臨床研究組織。 2022 年，醫院和診斷中心細分市場佔據最大佔有率。

根據國家/地區，歐洲 dPCR 和 qPCR 市場分為英國、德國、法國、西班牙、義大利和歐洲其他地區。 2022 年，德國主導了歐洲 dPCR 和 qPCR 市場。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、樂普醫療科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc 在歐洲dPCR 和qPCR 市場運作。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲 dPCR 和 qPCR 市場格局

  • 概述
  • 歐洲PEST分析

第 5 章：歐洲 dPCR 和 qPCR 市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的發生率增加
    • 基因合成的投資和資金不斷增加
    • PCR 技術的技術進步
  • 市場限制
    • PCR 系統成本高
    • 與 qPCR 相關的技術限制
  • 市場機會
    • 新興國家擴大採用 PCR 方法
  • 未來的趨勢
    • 微滴式數位PCR的發展
  • 影響分析：

第 6 章：dPCR 和 qPCR 市場 - 歐洲市場分析

  • 歐洲 dPCR 和 qPCR 市場收入，2022 - 2030

第 7 章：歐洲 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按治療方式

  • 概述
  • 2022 年和 2030 年歐洲 dPCR 和 qPCR 市場收入佔有率（按治療方式）（%）
  • 定量PCR
  • 數位PCR

第 8 章：歐洲 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年歐洲 dPCR 和 qPCR 市場收入佔有率（按產品）（%）
  • 試劑及耗材
  • 儀器
  • 軟體與服務

第 9 章：歐洲 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年和 2030 年歐洲 dPCR 和 qPCR 市場收入佔有率（按應用）（%）
  • 研究應用
  • 臨床應用
  • 法醫應用

第 10 章：歐洲 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年歐洲 dPCR 和 qPCR 市場收入佔有率（按最終用戶）（%）
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究實驗室和學術機構
  • 法醫實驗室
  • 臨床研究組織

第 11 章：歐洲 dPCR 和 qPCR 市場 - 國家分析

    • 歐洲 dPCR 和 qPCR 市場（按國家）
      • 英國
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 歐洲其他地區

第 12 章：dPCR 和 qPCR 市場產業格局

  • 概述
  • 歐洲 dPCR 和 qPCR 市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第 14 章：附錄

Product Code: BMIRE00029879

The Europe dPCR and qPCR market was valued at US$ 2,573.83 million in 2022 and is expected to reach US$ 5,182.96 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive Europe dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In June 2020, as per Novartis AG (Switzerland) report, ~15,000 individuals have sickle cell disease, and 270 newborns are diagnosed with the condition every year. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium--, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space. Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the Europe dPCR and qPCR market.

Europe dPCR and qPCR Market Overview

The European dPCR and qPCR market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Government and private funding for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemption for R&D and new biotech startups are expected to favor the European dPCR and qPCR market growth over the forecast years. However, the effect of Brexit on the European Union may lead to the loss of various alliances, partnerships, ventures, and collaborations, negatively impacting the European dPCR and qPCR market.

Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Europe dPCR and qPCR Market Segmentation

The Europe dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Europe dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Europe dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Europe dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Europe dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Europe dPCR and qPCR market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Europe dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Europe Market Analysis

  • 6.1 Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Europe dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe dPCR and qPCR Market - Country Analysis

    • 11.1.1 Europe dPCR and qPCR Market, by Country
      • 11.1.1.1 UK
        • 11.1.1.1.1 UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.2 UK: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.1.3 UK: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.1.4 UK: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.1.4.1 UK: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.1.5 UK: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.2 Germany
        • 11.1.1.2.1 Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 Germany: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.2.3 Germany: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Germany: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.2.4.1 Germany: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.2.5 Germany: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.3 France
        • 11.1.1.3.1 France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 France: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.3.3 France: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.3.4 France: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.3.4.1 France: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.3.5 France: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Italy: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Italy: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Italy: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.4.4.1 Italy: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.4.5 Italy: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.2 Spain: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.5.3 Spain: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.5.4 Spain: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.5.4.1 Spain: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.5.5 Spain: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.2 Rest of Europe: Europe dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.1.6.3 Rest of Europe: Europe dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.1.6.4 Rest of Europe: Europe dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.1.6.4.1 Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.1.6.5 Rest of Europe: Europe dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Europe dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Europe dPCR and qPCR Market Segmentation
  • Table 2. Europe dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Germany: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Germany: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. France: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. France: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Italy: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Spain: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Spain: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Spain: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Europe: Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Europe: Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Europe: Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Europe: Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Europe dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Europe dPCR and qPCR Market
  • Table 35. Glossary of Terms, Europe dPCR and qPCR Market

List Of Figures

  • Figure 1. Europe dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 7. Quantitative PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Digital PCR: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 10. Reagents & Consumables: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Instruments: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Software & Services: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 14. Research Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Clinical Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Forensic Application: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Europe dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 18. Hospitals and Diagnostic Centers: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnology Companies: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Research Laboratories and Academic Institutes: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Forensic Laboratories: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Clinical Research Organizations: Europe dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 24. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Germany: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. France: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Italy: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Spain: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Rest of Europe: Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Growth Strategies in Europe dPCR and qPCR Market